From January 18, 2024 to March 31, 2024, the company has repurchased 2,476,300 shares, representing 0.27% for HKD 60.36 million. With this, the company has completed the repurchase of 2,476,300 shares, representing 0.27% for HKD 60.36 million under the buyback announced on January 19, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.68 CNY | +1.31% | -1.53% | +10.48% |
May. 14 | Livzon Pharmaceutical Group Cancels Share Options | MT |
May. 14 | Livzon Pharmaceutical Declares Final Dividend for 2023 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.48% | 4.35B | |
+38.51% | 727B | |
+32.57% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.14% | 205B | |
-5.69% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Tranche Update on Livzon Pharmaceutical Group Inc.'s Equity Buyback Plan announced on January 19, 2024.